1. Home
  2. SINT vs NXL Comparison

SINT vs NXL Comparison

Compare SINT & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$1.92

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.36

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
NXL
Founded
1996
2010
Country
United States
United States
Employees
N/A
8
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
10.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SINT
NXL
Price
$1.92
$0.36
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
46.2K
227.0K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
N/A
EPS
N/A
N/A
Revenue
$1,018,000.00
N/A
Revenue This Year
$30.26
$15.52
Revenue Next Year
$413.20
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$0.31
52 Week High
$6.78
$2.00

Technical Indicators

Market Signals
Indicator
SINT
NXL
Relative Strength Index (RSI) 40.43 38.74
Support Level $1.93 $0.35
Resistance Level $2.98 $0.46
Average True Range (ATR) 0.15 0.04
MACD -0.02 -0.02
Stochastic Oscillator 27.59 12.46

Price Performance

Historical Comparison
SINT
NXL

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: